Rubicon Research Share Price in Focus as General Atlantic Sells 8.37% Stake for Rs 2,292 Crore

Rubicon Research share price is in focus after General Atlantic Singapore RR Pte Ltd, the company's foreign promoter, sold 1.38 crore equity shares, representing 8.37% of Rubicon Research's paid-up equity, for Rs 2,291.61 crore. The shares were sold at Rs 1,660 apiece through block deals to 10 domestic and global institutional investors.

General Atlantic held a 35.83% stake in Rubicon Research as of June 2026, prior to this transaction. Buyers of the shares sold by General Atlantic included Kotak Mahindra Mutual Fund, Nomura India Investment Fund Mother Fund, HDFC AMC, ICICI Prudential AMC, SBI Mutual Fund, VEMF-A LP, Axis MF, TIMF Holdings, Aranda Investments, and PI Opportunities AIF V LLP.

Click Here – Get Free Investment Predictions

About Rubicon Research

Rubicon Research is a pharmaceutical company that has drawn significant private equity backing from General Atlantic, a global growth equity firm. The company's operations and listing have attracted interest from a broad set of institutional investors, reflected in the diverse buyer list for this block deal.

Broad Institutional Participation in the Block Deal

Track Rubicon Research's live price on the Univest Screener

The wide range of buyers, spanning leading domestic mutual funds like Kotak Mahindra, HDFC AMC, ICICI Prudential AMC, SBI Mutual Fund, and Axis MF, alongside global institutional names like Nomura and Aranda Investments, indicates broad-based confidence in Rubicon Research's business fundamentals at the transacted price of Rs 1,660 per share.

Such diversified institutional participation in a block deal is generally viewed constructively, as it distributes ownership across multiple long-term investors rather than concentrating the stake with a single buyer.

Rubicon Research Stake Sale Details

Parameter	Details
Seller	General Atlantic Singapore RR Pte Ltd (foreign promoter)
Shares Sold	1.38 crore equity shares
Stake Sold	8.37% of paid-up equity
Transaction Value	Rs 2,291.61 crore
Transaction Price	Rs 1,660 per share
General Atlantic's Pre-Sale Stake	35.83% (as of June 2026)
Number of Buyers	10 domestic and global institutional investors

Conclusion

Rubicon Research share price will remain in focus following this significant stake sale by General Atlantic. The broad-based institutional participation among the buyers suggests continued confidence in the company's fundamentals, even as the foreign promoter reduces its overall holding. Consult a SEBI-registered financial advisor before making any investment decision.

Download the Univest iOS App or Univest Android App to track Rubicon Research's live price after the stake sale.

FAQs on Rubicon Research Share Price

Why is Rubicon Research share price in focus today?

Ans. Rubicon Research share price is in focus after foreign promoter General Atlantic Singapore RR Pte Ltd sold an 8.37% stake worth Rs 2,291.61 crore through block deals to 10 domestic and global institutional investors.

Who is Rubicon Research's foreign promoter?

Ans. Rubicon Research's foreign promoter is General Atlantic Singapore RR Pte Ltd, an entity linked to the global growth equity firm General Atlantic, which held a 35.83% stake in the company as of June 2026.

Who bought the Rubicon Research shares sold by General Atlantic?

Ans. Buyers included Kotak Mahindra Mutual Fund, Nomura India Investment Fund Mother Fund, HDFC AMC, ICICI Prudential AMC, SBI Mutual Fund, VEMF-A LP, Axis MF, TIMF Holdings, Aranda Investments, and PI Opportunities AIF V LLP.

What price were Rubicon Research shares sold at?

Ans. The Rubicon Research shares in this block deal were sold at Rs 1,660 per share, for a total transaction value of Rs 2,291.61 crore.

Does General Atlantic still hold a stake in Rubicon Research?

Ans. Yes, this transaction represents a partial stake sale of 8.37%. General Atlantic held a 35.83% stake in Rubicon Research prior to this sale and retains a substantial remaining position in the company.